# The desmosomal cadherin Desmoglein-2 controls extracellular matrix expression and remodeling via NF-κB signaling in keratinocytes

**Authors:** Sadie E. Hunter, Zara T. Patel, Beatriz Mateo, Joshua M. Powers, Austin Y. Shull, Adi D. Dubash

PMC · DOI: 10.3389/fcell.2025.1691260 · Frontiers in Cell and Developmental Biology · 2025-10-30

## TL;DR

This study shows that Desmoglein-2 regulates extracellular matrix and remodeling through NF-κB signaling in skin cells.

## Contribution

The paper reveals a novel link between Desmoglein-2 and NF-κB signaling in controlling ECM expression and remodeling in keratinocytes.

## Key findings

- Loss of Dsg2 increases ECM and MMP expression in keratinocytes.
- NF-κB signaling is elevated in Dsg2-deficient cells and mediates ECM/MMP changes.
- RelA knockdown rescues the enhanced migratory ability of Dsg2-deficient cells.

## Abstract

Desmogleins are transmembrane cadherin proteins and obligate members of the desmosome, a cell-cell adhesion complex which connects adjacent cells and provides structural integrity to tissues. While Desmogleins are well-known for their importance in maintenance of cell-cell junctions, several studies have also highlighted their role in signaling crosstalk with cell-matrix adhesions and the extracellular matrix (ECM). We have recently shown that Desmoglein-2 (Dsg2) controls cell spreading on ECM substrates (fibronectin and collagen) and phosphorylation of focal adhesion proteins via Rap1 GTPase signaling. In our current study, we show that loss of Dsg2 in keratinocytes enhances the expression of ECM proteins and matrix metalloproteinases (MMPs), an effect that was not recapitulated upon loss of Desmocollin-2 (Dsc2) or loss of Dsg2 in other epithelial cell types. Signaling pathways well-known to control ECM function (TGF-β and Rho) were not involved in Dsg2-mediated changes in ECM gene expression, but an analysis of global transcriptome changes by RNA sequencing identified major changes in Nuclear Factor-kappa B (NF-κB)-mediated signaling in Dsg2-deficient cells. Interestingly, NF-κB (RelA) activation is elevated in Dsg2-deficient cells, and knockdown of RelA rescued both the enhanced expression of ECM/MMP genes and the enhanced migratory ability of Dsg2-deficient cells. Taken together, this study has identified an important link between Dsg2 and NF-κB signaling involved in controlling matrix production and remodeling, which has relevance for multiple processes in the epidermis such as wound healing and psoriasis.

## Linked entities

- **Genes:** DSG2 (desmoglein 2) [NCBI Gene 1829], DSC2 (desmocollin 2) [NCBI Gene 1824], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970]
- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** psoriasis (MONDO:0005083)

## Full-text entities

- **Genes:** FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, DSG2 (desmoglein 2) [NCBI Gene 1829] {aka CDHF5, HDGC}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, DSC2 (desmocollin 2) [NCBI Gene 1824] {aka ARVD11, CDHF2, DG2, DGII/III, DSC3}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}
- **Diseases:** psoriasis (MESH:D011565)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12611794/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12611794/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12611794/full.md

---
Source: https://tomesphere.com/paper/PMC12611794